Cargando…
Optimizing Fixed-Ratio Combination Therapy in Type 2 Diabetes
The progressive nature of type 2 diabetes (T2D) means that many patients will require basal insulin therapy at some point in the course of the disease due to β-cell failure. As basal insulin primarily targets fasting plasma glucose, patients may still experience considerable postprandial glucose exc...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6824345/ https://www.ncbi.nlm.nih.gov/pubmed/30610613 http://dx.doi.org/10.1007/s12325-018-0868-9 |